BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22080959)

  • 21. The new landscape of retinal gene therapy.
    Ku CA; Pennesi ME
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New methods of the treatment of retinal dystrophies].
    Langrová H; Kratochvílová V
    Cesk Slov Oftalmol; 2013 Aug; 69(3):106-9. PubMed ID: 24437957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies.
    Garanto A
    Adv Exp Med Biol; 2019; 1185():71-77. PubMed ID: 31884591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hereditary retinal dystrophies].
    Kellner U; Renner AB; Herbst SM; Kellner S; Weinitz S; Weber BH
    Klin Monbl Augenheilkd; 2012 Feb; 229(2):171-93; quiz 194-6. PubMed ID: 22241577
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging Gene Therapy Treatments for Inherited Retinal Diseases.
    Bakall B; Hariprasad SM; Klein KA
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):472-478. PubMed ID: 30021033
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene Therapy for Inherited Retinal Disorders: Update on Clinical Trials.
    Michalakis S; Gerhardt M; Rudolph G; Priglinger S; Priglinger C
    Klin Monbl Augenheilkd; 2021 Mar; 238(3):272-281. PubMed ID: 33784790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
    Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.
    Talib M; Boon CJF
    Asia Pac J Ophthalmol (Phila); 2020; 9(3):159-179. PubMed ID: 32511120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.
    Maguire AM; Bennett J; Aleman EM; Leroy BP; Aleman TS
    Mol Ther; 2021 Feb; 29(2):442-463. PubMed ID: 33278565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary Retinal Dystrophy.
    Hohman TC
    Handb Exp Pharmacol; 2017; 242():337-367. PubMed ID: 28035529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.
    Gerard X; Garanto A; Rozet JM; Collin RW
    Adv Exp Med Biol; 2016; 854():517-24. PubMed ID: 26427454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in somatic gene therapy of retinal degeneration in the animal model].
    Schlichtenbrede FC; Sarra GM; Ali RR; Wiedemann P; Reichel MB
    Ophthalmologe; 2002 Apr; 99(4):259-65. PubMed ID: 12058500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited retinal diseases: Therapeutics, clinical trials and end points-A review.
    Georgiou M; Fujinami K; Michaelides M
    Clin Exp Ophthalmol; 2021 Apr; 49(3):270-288. PubMed ID: 33686777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
    Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
    Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.
    Kumaran N; Moore AT; Weleber RG; Michaelides M
    Br J Ophthalmol; 2017 Sep; 101(9):1147-1154. PubMed ID: 28689169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
    Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [RPE65-associated retinal dystrophies: gene therapy preserves vision].
    Gerhardt MJ; Michalakis S; Rudolph G; Priglinger C; Priglinger SG
    MMW Fortschr Med; 2022 Feb; 164(Suppl 4):40-41. PubMed ID: 35146717
    [No Abstract]   [Full Text] [Related]  

  • 38. [RPE65-retinal Dystrophies: From the Spectrum of the Clinical Picture to Gene Therapy].
    Stingl K; Priglinger C
    Klin Monbl Augenheilkd; 2024 Mar; 241(3):257-258. PubMed ID: 38508213
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilateral Subretinal Voretigene Neparvovec-rzyl (Luxturna) Gene Therapy.
    Weng CY
    Ophthalmol Retina; 2019 May; 3(5):450. PubMed ID: 31044739
    [No Abstract]   [Full Text] [Related]  

  • 40. Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies.
    den Hollander AI; Black A; Bennett J; Cremers FP
    J Clin Invest; 2010 Sep; 120(9):3042-53. PubMed ID: 20811160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.